SPONSOR
Wake Forest University Health Sciences
Total Trials
17
Recruiting
17
Phases
Phase 1, Phase 2, EARLY_Phase 1
Conditions studied: Intra-Abdominal HypertensionCancerGastrointestinal CancerHypertensionHypertension in PregnancyChest PainHeart Failure With Preserved Ejection FractionNon Hodgkin LymphomaHeart; Functional DisturbanceHodgkin Lymphoma
Wake Forest University Health Sciences is a clinical research sponsor with 17 registered studies on ClinicalTrials.gov, of which 17 are actively recruiting participants. Research covers conditions including Intra-Abdominal Hypertension, Cancer, Gastrointestinal Cancer, Hypertension.
The trial portfolio spans Phase 1, Phase 2, EARLY_Phase 1 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Wake Forest University Health Sciences
How many clinical trials has Wake Forest University Health Sciences sponsored?
ClinicalMetric currently tracks 17 clinical trials sponsored by Wake Forest University Health Sciences, of which 17 are actively recruiting participants. These trials cover conditions including Intra-Abdominal Hypertension, Cancer, Gastrointestinal Cancer. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Wake Forest University Health Sciences research focus on?
Wake Forest University Health Sciences clinical trials span Intra-Abdominal Hypertension, Cancer, Gastrointestinal Cancer, Hypertension, Hypertension in Pregnancy, and additional conditions. The research pipeline includes Phase 1, Phase 2, EARLY_Phase 1 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Wake Forest University Health Sciences clinical trial?
To participate in a Wake Forest University Health Sciences trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Wake Forest University Health Sciences trials with current recruitment status updated daily.
Clinical Trials by Wake Forest University Health Sciences
NCT06876896
Recruiting
Intra-abdominal Pressure (IAP) During PFA Treatment of A-fib/ A-Flutter
Intra-Abdominal Hypertension
NCT06489041
Recruiting
Evaluating Microarray Pharmacogenetic Testing in Cancer Patients
Cancer
NCT07356518
Recruiting
Telehealth and Remote Blood Pressure
Hypertension
NCT05897632
Recruiting
CARE-CP (Testing a Cardiovascular Ambulatory Rapid Evaluation for Patients With Chest Pain)
Chest Pain
NCT07413198
Recruiting
BOOST: Blended Onsite and Offsite Structured Exercise Training and Coaching
Heart Failure With Preserved Ejection Fraction
NCT05595577
Recruiting
Improving Exercise Capacity With a Tailored Physical Activity Intervention
Non Hodgkin Lymphoma
NCT00900471
Recruiting
Collection and Storage of Tissue Samples From Patients Undergoing Surgery For Suspected Solid Tumors
Unspecified Adult Solid Tumor, Protocol Specific
NCT07031739
Recruiting
Sequential Multiple Assignment Randomized Trial to Reduce Food Insecurity
Uncontrolled Hypertension
NCT07227051
Recruiting
Optimizing Self-Monitoring Feedback Delivery for the Treatment of Overweight and Obesity
Obesity & Overweight
NCT05675722 Phase 1
Recruiting
Implantation Of Vaginal Construct For Patients With Vaginal Aplasia
Congenital Mullerian Duct Anomaly
NCT05854433
Recruiting
Brain Structure and Clinical Endpoints in Myotonic Dystrophy Type 2
Myotonic Dystrophy Type 2
NCT04752293
Recruiting
Pediatric Hypertension and the Renin-Angiotensin SystEm (PHRASE)
Hypertension
NCT02422641 Phase 2
Recruiting
Prospective Evaluation Of High-Dose Systemic Methotrexate In Patients With Breast Cancer And Leptomeningeal Metastasis
Metastatic Breast Cancer
NCT05353452
Recruiting
Collaborative Care in Posttraumatic Epilepsy
Epilepsy, Post-Traumatic
NCT05871606 Phase 1
Recruiting
Inhaled Nitric Oxide in Acute Ischemic Stroke Patients Undergoing Mechanical Thrombectomy
Cerebrovascular Disorders
NCT04677816 Phase 2
Recruiting
Impact of Vitamin D Supplementation on the Rate of Pathologic Complete Response in Vitamin D Deficient Patients
Triple Negative Breast Cancer
NCT05707871 EARLY_Phase 1
Recruiting
Cardiovascular Effects of Very Low Nicotine Content Cigarettes
Tobacco Use
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology